Amgen

Amgen Signs Value-Based Deal for Enbrel (AMGN)
Investopedia
Thu, 02/23/17 - 09:39 pm
Amgen
Enbrel
rheumatoid arthritis
In Amgen-Sandoz SCOTUS case, biosim makers lambaste ruling's 6-month exclusivity gift
Fierce Pharma
Wed, 02/22/17 - 09:44 am
Amgen
Sandoz
Supreme Court
biosimilars
Amgen and the BPCIA Patent Dance – Redux
FDA Law Blog
Mon, 02/20/17 - 10:07 am
Amgen
patents
BPCIA
FDA
Sandoz
Neupogen
generics
Genentech
Avastin
With Siliq approval, can Amgen and AZ's trash become Valeant's treasure?
Fierce Pharma
Thu, 02/16/17 - 10:11 am
Siliq
Amgen
AstraZeneca
Valeant Pharmaceuticals
chronic plaque psoriasis
Sanofi confident in case to overturn Praluent ban
BioPharma Dive
Sat, 02/11/17 - 12:47 pm
Sanofi
Praluent
Regeneron
Amgen
Repatha
Sanofi, Regeneron win a crucial stay of execution on Praluent
Endpoints
Wed, 02/8/17 - 09:36 pm
Sanofi
Regeneron
Praluent
Amgen
Repatha
FDA approves Amgen drug for secondary hyperparathyroidism
Yahoo/Reuters
Wed, 02/8/17 - 09:18 am
FDA
Amgen
secondary hyperparathyroidism
kidney disease
etelcalcetide
Amgen's Repatha wins in outcomes trial, but is the score high enough?
Fierce Pharma
Mon, 02/6/17 - 12:04 pm
Amgen
Repatha
drug launches
New outcomes data could unlock Repatha's potential, says Amgen
PM Live
Mon, 02/6/17 - 12:01 pm
Repatha
Amgen
Amgen: Who Says Biotech’s Dead?
Barron's
Sat, 02/4/17 - 09:57 am
Amgen
Amgen beats Street 4Q forecasts
Yahoo/AP
Fri, 02/3/17 - 10:09 am
Amgen
earnings
Amgen Cholesterol-Lowering Drug Repatha Cuts Heart-Related Adverse Events in Big Study
TheStreet.com
Fri, 02/3/17 - 10:06 am
Amgen
Repatha
cholesterol
Transcript of Pharma CEOs Meeting With Trump
Investors Hub
Wed, 02/1/17 - 09:45 am
Donald Trump
Eli Lilly
Merck
Amgen
Celgene
JNJ
Novartis
drug pricing
Pharma goes to Washington, Trump talks pricing
BioPharma Dive
Wed, 02/1/17 - 09:41 am
pharma industry
drug pricing
Donald Trump
Eli Lilly
Amgen
Merck
Novartis
Celgene
JNJ
Key FDA Decision And Trial Dates In February
Seeking Alpha
Mon, 01/30/17 - 11:03 pm
FDA
Amgen
Valeant Pharmaceuticals
Amphastar
Egalet
Lexicon Pharmaceuticals
Amicus Therapeutics
Axovant
Amgen Gets EU Nod for Humira Biosimilar
Investopedia
Mon, 01/30/17 - 10:54 pm
Amgen
Humira
biosimilars
ABP 501
Novartis silently yanks a troubled biosimilar application; Chinese antibody developer draws $39M round
Endpoints
Sun, 01/29/17 - 11:53 am
Novartis
biosimilars
Zioxtenzo
Europe
Amgen
Neulasta
China
Novartis says court battle will delay its Enbrel copy until 2018 at least
Yahoo/Reuters
Wed, 01/25/17 - 09:58 am
Novartis
Enbrel
patents
Erelzi
Amgen
biosimilars
rheumatoid arthritis
Amgen Fight Over Copies of Biotech Drugs Gets High Court Review
Bloomberg
Sat, 01/14/17 - 03:35 pm
Amgen
Supreme Court
Neupogen
Novartis
Sandoz
biosimilars
When it comes to PCSK9s, payers resisted — and sales flopped
Medical Marketing and Media
Wed, 01/11/17 - 09:54 am
PCSK9 inhibitors
payers
Amgen
Sanofi
Regeneron
Repatha
Praluent

Pages